To support companies during their strategic planning, Biosova offers both generation of general discussion documents to summarize potential avenues for growth as well as on-demand business
Pipeline strategy for global pharma company Biosova supported the development of pharmaceutical pipeline strategy in the departments oncology, immuno-oncology,
immunology and neurology (projects in phase 0 to 3) by generating an evaluative summary for board members (including the CEO).
Product evaluation of diagnostic device for microbiology of a German medtech company
To allow an informed decision regarding the out-licensing of a PCR-based diagnostic device, Biosova performed interviews with over 60 users Europe-wide, delivered a detailed account and
service analysis as well as a sales process optimization study.
Discussion documents for executive management of top German medical technology company
Biosova delivered a comprehensive report summarizing market trends, upcoming technologies and competitive forces.
Discussion documents for executive management of global healthcare company
Via the analysis of the market environment, the competitive landscape and potential portfolio gaps Biosova evaluated future growth opportunities.